Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of eleven abstracts covering research in amyotrophic lateral sclerosis (ALS) at the 2025 Muscular Dystrophy Association ...

JERSEY CITY, N.J., March 12, 2025 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of eleven abstracts covering research in amyotrophic lateral ...

Mitsubishi Tanabe Pharma and bluebird bio were both bought by investors during the month, while private equity firms ...

Pertussis Treatment Market Pertussis Medications and Vaccinations Leading Therapeutic Approaches Driving Stance of Companies in the Market: ...

Mitsubishi Tanabe Pharma is being sold to Bain Capital for about $3.3 billion. Eisai expects a Leqembi "expansion phase" on the horizon. And more. 1. Astellas shifts investment focus to later ...

Advarra, the market leader in regulatory review solutions and clinical research technology, today announced the launch of Oncology Research Pulse, a new content-driven, thought leadership initiative ...

Tell your healthcare provider right away or go to the nearest emergency room if you have any of the following symptoms: hives; swelling of the lips, tongue, or face; fainting; breathing problems; ...

Last month, Ropes & Gray, Morrison & Foerster and Big Four Japanese firm Mori Hamada were seen advising in Boston-based Bain ...

Global private equity and venture capital deal value reached $37.93 billion in February, up 26.6% from January, according to ...

Blackstone Inc. is buying a company that helps drugmakers run clinical trials in Japan, adding to growing interest from ...

BLACKSTONE is buying a company that helps drugmakers run clinical trials in Japan, adding to growing interest from private ...